ClinicalTrials.gov
ClinicalTrials.gov Menu

A Prospective Registry for Febrile Events in Patients With Malignant Hemopathies or Subjected to Haematopoietic Stem Cell Transplant (HEMA E-CHART)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01069887
Recruitment Status : Completed
First Posted : February 17, 2010
Last Update Posted : February 24, 2010
Sponsor:
Collaborator:
Pagano L, Aversa F, Locatelli F, Nosari A,Rossi G, Viale P
Information provided by:
Catholic University of the Sacred Heart

Brief Summary:

Hema e-chart is an electronic case record that can be changed in real time and is based on the chronological organisation of the infective events and the therapies prescribed. It allows the collection of all personal, epidemiological, diagnostic and therapeutic data pertaining to the patient, processing it and analysing the results.

Aims and objectives of the project

The aims of this registry are:

  • To assess how many suspected fungal-related febrile episodes identify an infective fungal agent
  • To have a clear view of the diagnostic and therapeutic actions in the management of onco-haematological patients with suspected fungal-related febrile episodes
  • To assess the impact of anti-fungal therapy on the timing of chemotherapy and transplant planning
  • Perform drug-epidemiology relationship analyses, observe toxicity and interactions with antifungal therapies by means of the creation of a national database of fungal infections in patients affected by malignant haemopathies

Design

  • A multicentre, prospective registry for monitoring invasive fungal infections in onco-haematological patients
  • Registration criteria: patients with newly diagnosed malignant haematological diseases (acute and chronic myeloid and lymphoid leukaemia, multiple myeloma, non-Hodgkin's and Hodgkin's lymphoma, aplastic anaemia, myelodysplastic syndromes), or patients who, as a result of onco-haematological pathologies, have undergone allogenic or autologous haematopoietic cell transplants, and have ongoing febrile episodes . The recording of consecutive febrile events is required
  • Data collection for each individual patient will be performed according to the method shown in the enclosed flow chart. In the case of a new episode for an existing patient, said new episode will be recorded in the same case record as a new event. All collected data will be coded into the database
  • Information relating to about 500 suspected fungal-related febrile events requiring antifungal therapy is expected to be collected from approximately 60 centres over the course of 18 months
  • Data collection for each event may be performed following the provision of written informed consent, which will be obtained from each patient participating in this health survey
  • The data collected will be handled and stored in full compliance with the Italian laws governing privacy
  • Hema e-chart is a non-interventional registry

Condition or disease
Hematological Malignancies Stem Cell Transplantation

  Show Detailed Description

Study Type : Observational
Actual Enrollment : 3000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Non-interventional Multicentre Prospective Registry to Monitor the Incidence of Invasive Fungal Infections and to Monitor the Diagnostic and Therapeutic Management of Suspected Fungal-related Febrile Episodes in Patients With Malignant Hemopathies or Subjected to Haematopoietic Cell Transplant for the Treatment of Onco-haematological Diseases (HEMA E-CHART REGISTRY)
Study Start Date : March 2007
Actual Study Completion Date : March 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort
adult with hematological malignancies
pediatrics with hematological malignancies
pediatrics receiving stem cell transplant
adult receiving stem cell transplant



Primary Outcome Measures :
  1. number of febrile events [ Time Frame: 3 times/week ]

Secondary Outcome Measures :
  1. incidence of invasive fungal infections


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
patients with newly diagnosed malignant haematological diseases (acute and chronic myeloid and lymphoid leukaemia, multiple myeloma, non-Hodgkin's and Hodgkin's lymphoma, aplastic anaemia, myelodysplastic syndromes), or patients who, as a result of onco-haematological pathologies, have undergone allogenic or autologous haematopoietic cell transplants, and have ongoing febrile episodes
Criteria

Inclusion Criteria:

  • patients with newly diagnosed malignant haematological diseases (acute and chronic myeloid and lymphoid leukaemia, multiple myeloma, non-Hodgkin's and Hodgkin's lymphoma, aplastic anaemia, myelodysplastic syndromes), or patients who, as a result of onco-haematological pathologies, have undergone allogenic or autologous haematopoietic cell transplants, and have ongoing febrile episodes

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01069887


Locations
Italy
Hematology Institute - Catholic University
Rome, RM, Italy, 00168
Sponsors and Collaborators
Catholic University of the Sacred Heart
Pagano L, Aversa F, Locatelli F, Nosari A,Rossi G, Viale P

Publications of Results:
Other Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT01069887     History of Changes
Other Study ID Numbers: 578/06
First Posted: February 17, 2010    Key Record Dates
Last Update Posted: February 24, 2010
Last Verified: April 2009

Keywords provided by Catholic University of the Sacred Heart:
febrile events
invasive fungal infections
hematological patients

Additional relevant MeSH terms:
Invasive Fungal Infections
Mycoses